Twist Bioscience CorporationNASDAQ: TWST

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(4)

· Issued by Twist Bioscience Corporation

Summary by 6ix AI

Twist Bioscience Corporation will grant a total of 44,434 restricted stock units (RSUs, awards that convert into company shares as they vest) to 24 recently hired individuals, as an inducement material to their acceptance of employment with Twist.

Key details

  • The awards will be granted under Twist's Amended and Restated Inducement Equity Incentive Plan, in line with Nasdaq Listing Rule 5635(4), a Nasdaq rule covering equity awards given to induce people to join a company.
  • The inducement plan is used only for awards to people who were not previously Twist employees, or who join after a genuine break in employment.
  • For a portion of the RSUs, 25% vest on the one-year anniversary of the vesting commencement date and 1/16 vest on each quarterly anniversary after that, over a 48-month period.
  • For a further portion of the RSUs, 1/16 of the RSUs vest on each quarterly anniversary of the vesting commencement date, over a 48-month period.

What’s still pending

  • Under both vesting schedules described, vesting is subject to the employee's continued service through each vesting date.

6ix AI wrote this summary from the release below and checked it against the release.

SOUTH SAN FRANCISCO - As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) ('Twist' or the 'Company'), a mid-cap growth and value biotech company, announced that a total of 44,434 restricted stock units ('RSUs') will be granted to 24 recently hired individuals, in each case as an inducement material to their acceptance of employment with Twist.

The employment inducement awards will be granted under Twist's Amended and Restated Inducement Equity Incentive Plan and related form of restricted stock unit award agreement in accordance with Nasdaq Listing Rule 5635(4).

The inducement plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Twist, or following a bona fide period of non-employment, as an inducement material to such individuals entering into employment with Twist, pursuant to Nasdaq Listing Rule 5635(4).

A portion of the 44,434 RSUs vest over a 48-month period for each employee as follows: 25% vests on the one-year anniversary of the applicable vesting commencement date (the 'Vesting Commencement Date'), and 1/16 of the RSUs vest on each quarterly anniversary (or the last day of the month if no such day exists) of the Vesting Commencement Date thereafter, subject to the employee's continued service through each vesting date. A portion of the 44,434 RSUs vest over a 48-month period for each employee as follows: 1/16 of the RSUs vest on each quarterly anniversary (or the last day of the month if no such day exists) of the Vesting Commencement Date, subject to the employee's continued service through each vesting date.

About Twist Bioscience Corporation

At Twist Bioscience, our customizable solutions across the biological continuum raise the bar in diagnostics, therapeutics, industrial, agriculture and research markets.

We drive innovation with confidence, without compromise. Whether delivering oligos, genes, proteins, libraries, characterization data, antibody discovery solutions, or NGS workflow tools, our scientific expertise and exceptional customer experience help navigate complex challenges, all with precision and at the scale and speed customers require. By enhancing R&D efficiency at every turn, we give scientists more shots on goal - more experiments, more iterations, more chances for remarkable discoveries.

Together, we stand with customers in the relentless pursuit of progress, backed by enterprise reliability, to shape a healthier and more sustainable future for all.

Contact:

Angela Bitting

Tel: 925-202-6211

Email: abitting@twistbioscience.com

Amanda Houlihan

Tel: 774-265-5334

Email: ahoulihan@twistbioscience.com

(C) 2026 Electronic News Publishing, source ENP Newswire

Twist Bioscience Corporation on 6ix

Story so far

Earlier from Twist Bioscience

Later from Twist Bioscience

All Twist Bioscience news releases